...
vygr-img

Voyager Therapeutics Inc, Common Stock

VYGR

NSQ

$5.75

+$0.06

(1.05%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$316.28M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
8.7727
Volume info-icon
This is the total number of shares traded during the most recent trading day.
552.64K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.89
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.19 L
$11.72 H
$5.75

About Voyager Therapeutics Inc, Common Stock

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameVYGRSectorS&P500
1-Week Return-8.29%-2.12%-3%
1-Month Return7.28%-3.42%-0.73%
3-Month Return-8%-11.13%2.87%
6-Month Return-26.19%-5.74%7.17%
1-Year Return-27.58%3.97%25.31%
3-Year Return96.92%1.05%28.38%
5-Year Return-58.99%34.37%81.89%
10-Year Return-67.61%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue104.39M171.13M37.41M40.91M250.01M[{"date":"2019-12-31","value":41.76,"profit":true},{"date":"2020-12-31","value":68.45,"profit":true},{"date":"2021-12-31","value":14.97,"profit":true},{"date":"2022-12-31","value":16.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue119.73M108.75M73.79M6.19M4.44M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":90.83,"profit":true},{"date":"2021-12-31","value":61.63,"profit":true},{"date":"2022-12-31","value":5.17,"profit":true},{"date":"2023-12-31","value":3.71,"profit":true}]
Gross Profit104.39M62.38M37.41M40.91M245.57M[{"date":"2019-12-31","value":42.51,"profit":true},{"date":"2020-12-31","value":25.4,"profit":true},{"date":"2021-12-31","value":15.24,"profit":true},{"date":"2022-12-31","value":16.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin100.00%36.45%100.00%100.00%98.22%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":36.45,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.22,"profit":true}]
Operating Expenses156.07M143.74M111.03M91.74M127.99M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.1,"profit":true},{"date":"2021-12-31","value":71.14,"profit":true},{"date":"2022-12-31","value":58.78,"profit":true},{"date":"2023-12-31","value":82.01,"profit":true}]
Operating Income(51.68M)27.38M(73.62M)(50.84M)122.01M[{"date":"2019-12-31","value":-42.35,"profit":false},{"date":"2020-12-31","value":22.44,"profit":true},{"date":"2021-12-31","value":-60.34,"profit":false},{"date":"2022-12-31","value":-41.66,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense14.54M11.02M2.03M6.24M23.45M[{"date":"2019-12-31","value":62.01,"profit":true},{"date":"2020-12-31","value":46.99,"profit":true},{"date":"2021-12-31","value":8.66,"profit":true},{"date":"2022-12-31","value":26.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(43.60M)36.74M(71.20M)(46.39M)133.74M[{"date":"2019-12-31","value":-32.6,"profit":false},{"date":"2020-12-31","value":27.47,"profit":true},{"date":"2021-12-31","value":-53.24,"profit":false},{"date":"2022-12-31","value":-34.69,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes(2.77M)(1.66M)(5.17M)16.00K1.41M[{"date":"2019-12-31","value":-196.38,"profit":false},{"date":"2020-12-31","value":-117.83,"profit":false},{"date":"2021-12-31","value":-366.83,"profit":false},{"date":"2022-12-31","value":1.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(40.83M)38.40M(66.03M)(46.41M)132.33M[{"date":"2019-12-31","value":-30.86,"profit":false},{"date":"2020-12-31","value":29.02,"profit":true},{"date":"2021-12-31","value":-49.9,"profit":false},{"date":"2022-12-31","value":-35.07,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations(43.60M)36.74M(71.20M)(46.41M)132.33M[{"date":"2019-12-31","value":-32.95,"profit":false},{"date":"2020-12-31","value":27.76,"profit":true},{"date":"2021-12-31","value":-53.8,"profit":false},{"date":"2022-12-31","value":-35.07,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(40.83M)36.74M(66.03M)(46.41M)132.33M[{"date":"2019-12-31","value":-30.86,"profit":false},{"date":"2020-12-31","value":27.76,"profit":true},{"date":"2021-12-31","value":-49.9,"profit":false},{"date":"2022-12-31","value":-35.07,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)(1.27)0.95(1.90)(1.22)3.09[{"date":"2019-12-31","value":-41.1,"profit":false},{"date":"2020-12-31","value":30.74,"profit":true},{"date":"2021-12-31","value":-61.49,"profit":false},{"date":"2022-12-31","value":-39.48,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VYGR
Cash Ratio 7.81
Current Ratio 8.45

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VYGR
ROA (LTM) 1.57%
ROE (LTM) 10.22%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VYGR
Debt Ratio Lower is generally better. Negative is bad. 0.22
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.78

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VYGR
Trailing PE 8.71
Forward PE NM
P/S (TTM) 1.92
P/B 0.95
Price/FCF NM
EV/R 0.09
EV/Ebitda 1.02
PEG NM

FAQs

What is Voyager Therapeutics Inc share price today?

Voyager Therapeutics Inc (VYGR) share price today is $5.75

Can Indians buy Voyager Therapeutics Inc shares?

Yes, Indians can buy shares of Voyager Therapeutics Inc (VYGR) on Vested. To buy Voyager Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VYGR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Voyager Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Voyager Therapeutics Inc (VYGR) via the Vested app. You can start investing in Voyager Therapeutics Inc (VYGR) with a minimum investment of $1.

How to invest in Voyager Therapeutics Inc shares from India?

You can invest in shares of Voyager Therapeutics Inc (VYGR) via Vested in three simple steps:

  • Click on Sign Up or Invest in VYGR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Voyager Therapeutics Inc shares
What is Voyager Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Voyager Therapeutics Inc (VYGR) is $11.72. The 52-week low price of Voyager Therapeutics Inc (VYGR) is $5.19.

What is Voyager Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Voyager Therapeutics Inc (VYGR) is 8.7727

What is Voyager Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Voyager Therapeutics Inc (VYGR) is 0.95

What is Voyager Therapeutics Inc dividend yield?

The dividend yield of Voyager Therapeutics Inc (VYGR) is 0.00%

What is the Market Cap of Voyager Therapeutics Inc?

The market capitalization of Voyager Therapeutics Inc (VYGR) is $316.28M

What is Voyager Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Voyager Therapeutics Inc is VYGR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top